- Bend Bulletin main site
- Bend Bulletin archives
- Terms of Use
- Privacy Policy
- Contact the Bulletin
- Comments/Questions?
Published daily in Bend, Oregon, by Western Communications, Inc. Copyright 2007.
August 5, 2008
NEW YORK — ImClone Systems Inc.’s board of directors said Monday cancer drug partner Bristol-Myers Squibb Co.’s $4.5 billion buyout offer “substantially undervalues” the company, with Chairman Carl Icahn personally against the deal.
Despite....
